|
1
|
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
|
N Engl J Med
|
2002
|
7.84
|
|
2
|
Frequent mutation of the PIK3CA gene in ovarian and breast cancers.
|
Clin Cancer Res
|
2005
|
4.14
|
|
3
|
Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
|
J Clin Oncol
|
2008
|
3.54
|
|
4
|
An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
|
Gynecol Oncol
|
2011
|
2.89
|
|
5
|
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
|
Gynecol Oncol
|
2009
|
2.45
|
|
6
|
The rate of port-site metastases after 2251 laparoscopic procedures in women with underlying malignant disease.
|
Gynecol Oncol
|
2008
|
2.14
|
|
7
|
Incidence of venous thromboembolism after minimally invasive surgery in patients with newly diagnosed endometrial cancer.
|
Obstet Gynecol
|
2012
|
2.09
|
|
8
|
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.
|
Cancer
|
2006
|
2.03
|
|
9
|
Clinicopathologic features of rhabdomyosarcoma of gynecologic origin in adults.
|
Am J Surg Pathol
|
2007
|
1.79
|
|
10
|
Intravaginal brachytherapy alone for intermediate-risk endometrial cancer.
|
Int J Radiat Oncol Biol Phys
|
2005
|
1.77
|
|
11
|
Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
|
Gynecol Oncol
|
2003
|
1.74
|
|
12
|
Fertility-sparing radical abdominal trachelectomy for cervical carcinoma: technique and review of the literature.
|
Gynecol Oncol
|
2006
|
1.73
|
|
13
|
Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.
|
Int J Gynecol Cancer
|
2013
|
1.71
|
|
14
|
Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study.
|
Cancer
|
2006
|
1.71
|
|
15
|
Subcutaneous tumor implantation after laparoscopic procedures in women with malignant disease.
|
Obstet Gynecol
|
2004
|
1.69
|
|
16
|
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
|
Gynecol Oncol
|
2006
|
1.64
|
|
17
|
Molecular profiling of endometrial cancers from African-American and Caucasian women.
|
Gynecol Oncol
|
2005
|
1.62
|
|
18
|
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
|
Gynecol Oncol
|
2004
|
1.60
|
|
19
|
The revised 2009 FIGO staging system for endometrial cancer: should the 1988 FIGO stages IA and IB be altered?
|
Int J Gynecol Cancer
|
2011
|
1.60
|
|
20
|
Pelvic exenteration with curative intent for recurrent uterine malignancies.
|
Gynecol Oncol
|
2011
|
1.55
|
|
21
|
Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2.
|
J Clin Oncol
|
2007
|
1.54
|
|
22
|
The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
|
Gynecol Oncol
|
2012
|
1.52
|
|
23
|
The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center.
|
Gynecol Oncol
|
2006
|
1.51
|
|
24
|
Impact of operative start time on surgical outcomes in patients undergoing primary cytoreduction for advanced ovarian cancer.
|
Gynecol Oncol
|
2012
|
1.47
|
|
25
|
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: a case series and review of the literature.
|
Gynecol Oncol
|
2007
|
1.44
|
|
26
|
Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.
|
J Clin Oncol
|
2003
|
1.43
|
|
27
|
Pilot study prospectively evaluating the use of the measurement of preoperative sonographic endometrial thickness in postmenopausal patients with endometrial cancer.
|
Menopause
|
2005
|
1.43
|
|
28
|
Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.
|
Gynecol Oncol
|
2010
|
1.42
|
|
29
|
Ureteroileocecal appendicostomy based urinary reservoir in irradiated and nonirradiated patients.
|
J Urol
|
2009
|
1.38
|
|
30
|
The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
|
Gynecol Oncol
|
2010
|
1.37
|
|
31
|
Sentinel lymph node mapping for grade 1 endometrial cancer: is it the answer to the surgical staging dilemma?
|
Gynecol Oncol
|
2009
|
1.35
|
|
32
|
The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes.
|
Gynecol Oncol
|
2009
|
1.33
|
|
33
|
Improved survival for BRCA2-associated serous ovarian cancer compared with both BRCA-negative and BRCA1-associated serous ovarian cancer.
|
Cancer
|
2011
|
1.32
|
|
34
|
Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.
|
Gynecol Oncol
|
2005
|
1.32
|
|
35
|
The effect of maximal surgical cytoreduction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer.
|
Gynecol Oncol
|
2007
|
1.28
|
|
36
|
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
|
Gynecol Oncol
|
2006
|
1.28
|
|
37
|
Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the international Federation of gynecology and obstetrics and american joint committee on cancer staging systems.
|
J Clin Oncol
|
2009
|
1.27
|
|
38
|
Genetic analysis of the early natural history of epithelial ovarian carcinoma.
|
PLoS One
|
2010
|
1.25
|
|
39
|
Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?
|
Int J Radiat Oncol Biol Phys
|
2002
|
1.21
|
|
40
|
Surgical and pathologic outcomes of fertility-sparing radical abdominal trachelectomy for FIGO stage IB1 cervical cancer.
|
Gynecol Oncol
|
2008
|
1.20
|
|
41
|
A microRNA survival signature (MiSS) for advanced ovarian cancer.
|
Gynecol Oncol
|
2011
|
1.18
|
|
42
|
Clinicopathologic significance of defective DNA mismatch repair in endometrial carcinoma.
|
J Clin Oncol
|
2006
|
1.18
|
|
43
|
A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?
|
Gynecol Oncol
|
2004
|
1.17
|
|
44
|
Oncologic outcome of fertility-sparing radical trachelectomy versus radical hysterectomy for stage IB1 cervical carcinoma.
|
Gynecol Oncol
|
2008
|
1.16
|
|
45
|
A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
|
Gynecol Oncol
|
2009
|
1.14
|
|
46
|
Clinicopathologic analysis of early-stage sporadic ovarian carcinoma.
|
Am J Surg Pathol
|
2004
|
1.13
|
|
47
|
Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma.
|
Cancer
|
2004
|
1.12
|
|
48
|
Cystoscopic temporary ureteral catheterization during radical vaginal and abdominal trachelectomy.
|
Gynecol Oncol
|
2006
|
1.12
|
|
49
|
Establishing a sentinel lymph node mapping algorithm for the treatment of early cervical cancer.
|
Gynecol Oncol
|
2011
|
1.11
|
|
50
|
Clinicopathologic features of bone metastases and outcomes in patients with primary endometrial cancer.
|
Gynecol Oncol
|
2010
|
1.11
|
|
51
|
Radical vaginal versus abdominal trachelectomy for stage IB1 cervical cancer: a comparison of surgical and pathologic outcomes.
|
Gynecol Oncol
|
2008
|
1.10
|
|
52
|
Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
|
Gynecol Oncol
|
2006
|
1.10
|
|
53
|
Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus.
|
Gynecol Oncol
|
2003
|
1.09
|
|
54
|
Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma?
|
Am J Obstet Gynecol
|
2008
|
1.09
|
|
55
|
Total laparoscopic radical hysterectomy with pelvic lymphadenectomy using the argon-beam coagulator: pilot data and comparison to laparotomy.
|
Gynecol Oncol
|
2003
|
1.07
|
|
56
|
The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
|
Gynecol Oncol
|
2007
|
1.07
|
|
57
|
Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
|
Gynecol Oncol
|
2007
|
1.07
|
|
58
|
The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers.
|
Am J Obstet Gynecol
|
2005
|
1.06
|
|
59
|
A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma.
|
Cancer
|
2011
|
1.06
|
|
60
|
Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed?
|
Gynecol Oncol
|
2009
|
1.05
|
|
61
|
Clinical outcome of isolated serous tubal intraepithelial carcinomas (STIC).
|
Int J Gynecol Cancer
|
2013
|
1.04
|
|
62
|
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
|
Gynecol Oncol
|
2011
|
1.04
|
|
63
|
Single photon emission computed tomography SPECT-CT improves sentinel node detection and localization in cervical and uterine malignancy.
|
Gynecol Oncol
|
2010
|
1.03
|
|
64
|
A 2-year prospective study assessing the emotional, sexual, and quality of life concerns of women undergoing radical trachelectomy versus radical hysterectomy for treatment of early-stage cervical cancer.
|
Gynecol Oncol
|
2010
|
1.02
|
|
65
|
Cancer-related infertility in survivorship.
|
Int J Gynecol Cancer
|
2010
|
1.01
|
|
66
|
Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
|
J Natl Cancer Inst
|
2005
|
1.01
|
|
67
|
Surgical resection of recurrent endometrial carcinoma.
|
Gynecol Oncol
|
2006
|
1.01
|
|
68
|
Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.
|
Gynecol Oncol
|
2012
|
1.00
|
|
69
|
The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.
|
Gynecol Oncol
|
2010
|
0.99
|
|
70
|
Prognostic features of surgical stage I uterine carcinosarcoma.
|
Am J Surg Pathol
|
2007
|
0.99
|
|
71
|
Sentinel lymph node biopsy in the management of early-stage cervical carcinoma.
|
Gynecol Oncol
|
2011
|
0.98
|
|
72
|
Surgical cytoreduction in patients with metastatic uterine leiomyosarcoma at the time of initial diagnosis.
|
Gynecol Oncol
|
2012
|
0.98
|
|
73
|
Ovarian carcinoma screening in women at intermediate risk: impact on quality of life and need for invasive follow-up.
|
Cancer
|
2005
|
0.98
|
|
74
|
Laparoscopic and hand-assisted laparoscopic splenectomy for recurrent and persistent ovarian cancer.
|
Gynecol Oncol
|
2005
|
0.97
|
|
75
|
A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
|
Gynecol Oncol
|
2007
|
0.97
|
|
76
|
A prospective study of the feasibility and acceptability of a Web-based, electronic patient-reported outcome system in assessing patient recovery after major gynecologic cancer surgery.
|
Gynecol Oncol
|
2012
|
0.97
|
|
77
|
A pilot study using the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) as a clinical care tool to identify lower extremity lymphedema in gynecologic cancer survivors.
|
Gynecol Oncol
|
2010
|
0.97
|
|
78
|
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma.
|
Gynecol Oncol
|
2011
|
0.96
|
|
79
|
A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.
|
Oncologist
|
2009
|
0.96
|
|
80
|
Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.
|
Gynecol Oncol
|
2012
|
0.96
|
|
81
|
The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva.
|
Gynecol Oncol
|
2006
|
0.96
|
|
82
|
Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma.
|
Gynecol Oncol
|
2004
|
0.96
|
|
83
|
Ten-year experience with laparoscopy on a gynecologic oncology service: analysis of risk factors for complications and conversion to laparotomy.
|
Am J Obstet Gynecol
|
2004
|
0.96
|
|
84
|
A prospective randomized trial comparing patient-controlled epidural analgesia to patient-controlled intravenous analgesia on postoperative pain control and recovery after major open gynecologic cancer surgery.
|
Gynecol Oncol
|
2009
|
0.95
|
|
85
|
Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
|
Gynecol Oncol
|
2005
|
0.95
|
|
86
|
Exploratory analysis of serum CA-125 response to surgery and the risk of relapse in patients with FIGO stage IIIC ovarian cancer.
|
Gynecol Oncol
|
2009
|
0.95
|
|
87
|
Immunohistochemical expression of estrogen and progesterone receptors and outcomes in patients with newly diagnosed uterine leiomyosarcoma.
|
Gynecol Oncol
|
2011
|
0.95
|
|
88
|
Craniotomy for central nervous system metastases in epithelial ovarian carcinoma.
|
Gynecol Oncol
|
2002
|
0.94
|
|
89
|
Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy.
|
Gynecol Oncol
|
2007
|
0.94
|
|
90
|
The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions.
|
Gynecol Oncol
|
2006
|
0.94
|
|
91
|
Comparison of D&C and office endometrial biopsy accuracy in patients with FIGO grade 1 endometrial adenocarcinoma.
|
Gynecol Oncol
|
2009
|
0.94
|
|
92
|
Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
|
Gynecol Oncol
|
2004
|
0.94
|
|
93
|
A cross-sectional study of the psychosexual impact of cancer-related infertility in women: third-party reproductive assistance.
|
J Cancer Surviv
|
2010
|
0.93
|
|
94
|
Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer.
|
Gynecol Oncol
|
2006
|
0.93
|
|
95
|
Validated gene targets associated with curatively treated advanced serous ovarian carcinoma.
|
Gynecol Oncol
|
2012
|
0.93
|
|
96
|
Lysophosphatidic acid acyltransferase-beta (LPAAT-beta) is highly expressed in advanced ovarian cancer and is associated with aggressive histology and poor survival.
|
Cancer
|
2006
|
0.93
|
|
97
|
Screening and the prevention of gynecologic cancer: endometrial cancer.
|
Best Pract Res Clin Obstet Gynaecol
|
2005
|
0.91
|
|
98
|
Long-term survival after fertility-sparing surgery for epithelial ovarian cancer.
|
Int J Gynecol Cancer
|
2009
|
0.91
|
|
99
|
Peritoneal inclusion cysts: clinical characteristics and imaging features.
|
Eur Radiol
|
2012
|
0.91
|
|
100
|
Comparing surgical outcomes in obese women undergoing laparotomy, laparoscopy, or laparotomy with panniculectomy for the staging of uterine malignancy.
|
Ann Surg Oncol
|
2007
|
0.91
|
|
101
|
Tertiary cytoreduction in patients with recurrent ovarian carcinoma.
|
Gynecol Oncol
|
2004
|
0.91
|
|
102
|
Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancer.
|
Int J Radiat Oncol Biol Phys
|
2002
|
0.91
|
|
103
|
External validation of a nomogram predicting overall survival of patients diagnosed with endometrial cancer.
|
Gynecol Oncol
|
2012
|
0.90
|
|
104
|
A review of the challenges faced in the conservative treatment of young women with endometrial carcinoma and risk of ovarian cancer.
|
Gynecol Oncol
|
2009
|
0.90
|
|
105
|
Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer.
|
Obstet Gynecol
|
2012
|
0.90
|
|
106
|
Observations on the role of circumflex iliac node resection and the etiology of lower extremity lymphedema following pelvic lymphadenectomy for gynecologic malignancy.
|
Gynecol Oncol
|
2007
|
0.90
|
|
107
|
Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma.
|
Gynecol Oncol
|
2002
|
0.90
|
|
108
|
Postoperative pain medication requirements in patients undergoing computer-assisted (“Robotic”) and standard laparoscopic procedures for newly diagnosed endometrial cancer.
|
Ann Surg Oncol
|
2013
|
0.90
|
|
109
|
Palliative surgery for bowel obstruction in recurrent ovarian cancer:an updated series.
|
Gynecol Oncol
|
2003
|
0.89
|
|
110
|
Micrometastasis of endometrial cancer to sentinel lymph nodes: is it an artifact of uterine manipulation?
|
Gynecol Oncol
|
2010
|
0.89
|
|
111
|
Colorectal stents for palliation of large-bowel obstructions in recurrent gynecologic cancer: an updated series.
|
Gynecol Oncol
|
2008
|
0.89
|
|
112
|
Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients.
|
Gynecol Oncol
|
2009
|
0.88
|
|
113
|
Accuracy of preoperative endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma.
|
Gynecol Oncol
|
2008
|
0.88
|
|
114
|
Classification and regression tree (CART) analysis of endometrial carcinoma: Seeing the forest for the trees.
|
Gynecol Oncol
|
2013
|
0.87
|
|
115
|
Incidence of intestinal obstruction following intraperitoneal chemotherapy for ovarian tubal and peritoneal malignancies.
|
Gynecol Oncol
|
2009
|
0.87
|
|
116
|
The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.
|
Cancer
|
2005
|
0.87
|
|
117
|
Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer.
|
Gynecol Oncol
|
2012
|
0.87
|
|
118
|
Advances in the management of endometrial carcinoma.
|
Gynecol Oncol
|
2011
|
0.87
|
|
119
|
Incidence and management of bevacizumab-associated gastrointestinal perforations in patients with recurrent ovarian carcinoma.
|
Gynecol Oncol
|
2009
|
0.87
|
|
120
|
Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles.
|
Clin Cancer Res
|
2005
|
0.87
|
|
121
|
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer.
|
Gynecol Oncol
|
2011
|
0.87
|
|
122
|
Treatment patterns of FIGO Stage IB2 cervical cancer: a single-institution experience of radical hysterectomy with individualized postoperative therapy and definitive radiation therapy.
|
Gynecol Oncol
|
2008
|
0.86
|
|
123
|
Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
|
Gynecol Oncol
|
2008
|
0.86
|
|
124
|
Complex atypical hyperplasia of the uterus: characteristics and prediction of underlying carcinoma risk.
|
Am J Obstet Gynecol
|
2010
|
0.86
|
|
125
|
Expanding the indications for radical trachelectomy: a report on 29 patients with stage IB1 tumors measuring 2 to 4 centimeters.
|
Int J Gynecol Cancer
|
2013
|
0.86
|
|
126
|
Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
|
Gynecol Oncol
|
2006
|
0.86
|
|
127
|
Comparison of uterine malignancies that develop during and following tamoxifen therapy.
|
Gynecol Oncol
|
2005
|
0.86
|
|
128
|
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or less.
|
J Clin Oncol
|
2007
|
0.86
|
|
129
|
Breast cancer metastatic to abdomen and pelvis: role of surgical resection.
|
Gynecol Oncol
|
2003
|
0.86
|
|
130
|
Introduction of a computer-based surgical platform in the surgical care of patients with newly diagnosed uterine cancer: outcomes and impact on approach.
|
Gynecol Oncol
|
2012
|
0.85
|
|
131
|
The use of colorectal stents for palliation of large-bowel obstruction due to recurrent gynecologic cancer.
|
Gynecol Oncol
|
2004
|
0.85
|
|
132
|
Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
|
Gynecol Oncol
|
2005
|
0.85
|
|
133
|
Is endometrial carcinoma intrinsically more aggressive in elderly patients?
|
Cancer
|
2003
|
0.85
|
|
134
|
Molecular genetic characterization of tamoxifen-associated endometrial cancer.
|
Gynecol Oncol
|
2005
|
0.85
|
|
135
|
Resection of recurrent ovarian or fallopian tube carcinoma involving the liver.
|
Gynecol Oncol
|
2003
|
0.85
|
|
136
|
Patterns of recurrence and role of adjuvant chemotherapy in stage II-IV serous ovarian borderline tumors.
|
Gynecol Oncol
|
2010
|
0.85
|
|
137
|
Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers.
|
Obstet Gynecol
|
2014
|
0.85
|
|
138
|
Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.
|
Gynecol Oncol
|
2008
|
0.84
|
|
139
|
Evaluation of germline PTEN mutations in endometrial cancer patients.
|
Gynecol Oncol
|
2005
|
0.84
|
|
140
|
Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation.
|
Gynecol Oncol
|
2012
|
0.83
|
|
141
|
Patterns of recurrence in 1988 FIGO stage IC endometrioid endometrial cancer.
|
Gynecol Oncol
|
2011
|
0.83
|
|
142
|
A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.
|
Gynecol Oncol
|
2012
|
0.83
|
|
143
|
Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.
|
Gynecol Oncol
|
2008
|
0.83
|
|
144
|
Cervical conization and sentinel lymph node mapping in the treatment of stage I cervical cancer: is less enough?
|
Int J Gynecol Cancer
|
2014
|
0.82
|
|
145
|
What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?
|
Gynecol Oncol
|
2008
|
0.82
|
|
146
|
Early postoperative CT as a prognostic biomarker in patients with advanced ovarian, tubal, and primary peritoneal cancer deemed optimally debulked at primary cytoreductive surgery.
|
AJR Am J Roentgenol
|
2012
|
0.82
|
|
147
|
The value of MR imaging when the site of uterine cancer origin is uncertain.
|
Radiology
|
2011
|
0.82
|
|
148
|
The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions.
|
Gynecol Oncol
|
2004
|
0.81
|
|
149
|
The effects of CO2 pneumoperitoneum on the survival of women with persistent metastatic ovarian cancer.
|
Gynecol Oncol
|
2003
|
0.81
|
|
150
|
Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy.
|
Gynecol Oncol
|
2013
|
0.81
|
|
151
|
Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
|
Gynecol Oncol
|
2007
|
0.81
|
|
152
|
Platinum resistance and impaired survival in patients with advanced primary peritoneal carcinoma: matched-case comparison with patients with epithelial ovarian carcinoma.
|
Am J Obstet Gynecol
|
2008
|
0.81
|
|
153
|
Low risk of complications associated with the fenestrated peritoneal catheter used for intraperitoneal chemotherapy in ovarian cancer.
|
Gynecol Oncol
|
2008
|
0.81
|
|
154
|
The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer.
|
Clin Cancer Res
|
2012
|
0.81
|
|
155
|
Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
|
Gynecol Oncol
|
2013
|
0.81
|
|
156
|
Sister Society Meeting on Global Education Development and Collaboration: Meeting Report.
|
Int J Gynecol Cancer
|
2016
|
0.81
|
|
157
|
Transperitoneal laparoscopic pelvic and para-aortic lymph node dissection using the argon-beam coagulator and monopolar instruments: an 8-year study and description of technique.
|
Gynecol Oncol
|
2003
|
0.80
|
|
158
|
Postoperative external beam radiation therapy and concurrent cisplatin followed by carboplatin/paclitaxel for stage III (FIGO 2009) endometrial cancer.
|
Gynecol Oncol
|
2013
|
0.80
|
|
159
|
Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy?
|
Cancer
|
2008
|
0.80
|
|
160
|
Fifth International Conference on Ovarian Cancer: challenges and opportunities.
|
Gynecol Oncol
|
2005
|
0.80
|
|
161
|
Frozen-section evaluation of cervical adenocarcinoma at time of radical trachelectomy: pathologic pitfalls and the application of an objective scoring system.
|
Gynecol Oncol
|
2008
|
0.79
|
|
162
|
Location of disease in patients who die from endometrial cancer: a study of 414 patients from a single institution.
|
Int J Gynecol Cancer
|
2012
|
0.79
|
|
163
|
Brief report: total pelvic exenteration--A retrospective clinical needs assessment.
|
Psychooncology
|
2004
|
0.79
|
|
164
|
The significance of cytological mesothelial atypia diagnosed from peritoneal washings performed during risk-reducing salpingo-oophorectomy.
|
Gynecol Oncol
|
2006
|
0.79
|
|
165
|
Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies.
|
Int J Gynecol Cancer
|
2013
|
0.79
|
|
166
|
Endometrial cancer metastatic to infrarenal aortic lymph nodes unrecognized during laparoscopic inframesenteric aortic lymph node dissection.
|
Gynecol Oncol
|
2004
|
0.79
|
|
167
|
Aggressive surgery and ovarian cancer.
|
J Clin Oncol
|
2006
|
0.79
|
|
168
|
Incidence of lymph node and adnexal metastasis in endometrial stromal sarcoma.
|
Gynecol Oncol
|
2011
|
0.79
|
|
169
|
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers.
|
Gynecol Oncol
|
2010
|
0.78
|
|
170
|
Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers.
|
Gynecol Oncol
|
2009
|
0.78
|
|
171
|
Laparoscopic bilateral salpingo-oophorectomy in breast cancer patients after transverse rectus abdominus myocutaneous flap reconstructive surgery.
|
Gynecol Oncol
|
2005
|
0.78
|
|
172
|
Pelvic cytoreduction with rectosigmoid resection.
|
Gynecol Oncol
|
2006
|
0.78
|
|
173
|
Mesorectal lymph node involvement and prognostic implications at total pelvic exenteration for gynecologic malignancies.
|
Gynecol Oncol
|
2005
|
0.78
|
|
174
|
Endometrial sampling diagnosis of FIGO grade 1 endometrial adenocarcinoma with a background of complex atypical hyperplasia and final hysterectomy pathology.
|
Am J Obstet Gynecol
|
2009
|
0.77
|
|
175
|
Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer.
|
Cancer
|
2007
|
0.77
|
|
176
|
Surgical risk-reduction in carriers of BRCA mutations: where do we go from here?
|
Gynecol Oncol
|
2004
|
0.77
|
|
177
|
Prognostic significance of supradiaphragmatic lymphadenopathy identified on preoperative computed tomography scan in patients undergoing primary cytoreduction for advanced epithelial ovarian cancer.
|
Int J Gynecol Cancer
|
2010
|
0.77
|
|
178
|
Intraoperative hypothermia during primary surgical cytoreduction for advanced ovarian cancer: risk factors and associations with postoperative morbidity.
|
Gynecol Oncol
|
2013
|
0.77
|
|
179
|
Prognostic significance of the number of postoperative intraperitoneal chemotherapy cycles for patients with advanced epithelial ovarian cancer.
|
Int J Gynecol Cancer
|
2015
|
0.77
|
|
180
|
Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment: results of long-term follow-up.
|
Cancer
|
2008
|
0.76
|
|
181
|
Development of endometrial cancer after radiation treatment for cervical carcinoma.
|
Obstet Gynecol
|
2003
|
0.76
|
|
182
|
Tumoral displacement into fallopian tubes in patients undergoing robotically assisted hysterectomy for newly diagnosed endometrial cancer.
|
Int J Gynecol Pathol
|
2013
|
0.76
|
|
183
|
The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
|
Cancer
|
2002
|
0.76
|
|
184
|
Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
|
Int J Gynecol Cancer
|
2013
|
0.76
|
|
185
|
Enhancement of ovarian malignancy on clinical contrast enhanced MRI studies.
|
ISRN Obstet Gynecol
|
2013
|
0.75
|
|
186
|
Staging Lymphadenectomy in Patients With Clear Cell Carcinoma of the Ovary.
|
Int J Gynecol Cancer
|
2016
|
0.75
|
|
187
|
Ligation of an anatomic variant of renal vasculature during laparoscopic periaortic lymph node dissection: a cause of postoperative renal infarction.
|
Gynecol Oncol
|
2003
|
0.75
|
|
188
|
Follow-up study of the correlation between postoperative computed tomographic scan and primary surgeon assessment in patients with advanced ovarian, tubal, or peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease of 1 cm or smaller.
|
Int J Gynecol Cancer
|
2010
|
0.75
|
|
189
|
Superior pubic rami resection for isolated recurrent uterine cancer.
|
Gynecol Oncol
|
2006
|
0.75
|
|
190
|
Use of an ureteroileocecal appendicostomy urinary reservoir in patients with recurrent pelvic malignancies treated with radiation.
|
Gynecol Oncol
|
2004
|
0.75
|
|
191
|
Role of laparoscopy in the evaluation of the adnexa in patients with stage IV breast cancer.
|
Gynecol Oncol
|
2004
|
0.75
|
|
192
|
Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.
|
Gynecol Oncol
|
2012
|
0.75
|
|
193
|
Identification of prognostic factors after positive second-look surgery in epithelial ovarian carcinoma.
|
Gynecol Oncol
|
2006
|
0.75
|
|
194
|
Foreword.
|
Gynecol Oncol
|
2015
|
0.75
|
|
195
|
Radical surgery with individualized postoperative radiation for stage IB cervical cancer: oncologic outcomes and severe complications.
|
Int J Gynecol Cancer
|
2013
|
0.75
|
|
196
|
Laparoscopic findings during adnexal surgery in women with a history of nongynecologic malignancy.
|
Gynecol Oncol
|
2005
|
0.75
|
|
197
|
Proceedings from the 9th International Conference on Ovarian Cancer.
|
Gynecol Oncol
|
2011
|
0.75
|
|
198
|
Staging and surgical treatment.
|
Cancer Treat Res
|
2009
|
0.75
|
|
199
|
Adjuvant radiation for early stage endometrial cancer with lymphovascular invasion.
|
Gynecol Oncol
|
2008
|
0.75
|
|
200
|
Diagnostic x-rays and risk of epithelial ovarian carcinoma in Jews.
|
Ann Epidemiol
|
2002
|
0.75
|